|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Triplex operation for portal hypertension with esophageal variceal bleeding:report of 140 cases显示文摘BACKGROUND:Portal hypertension is a common dis ease. The surgical therapy of this disease focuses on the re sultant upper digestive tract bleeding, which can imperi patients’ life directly. This study was to evaluate the effect of triplex operation ( mesocaval C shunt with artificia graft, ligation of the coronary vein and splenic artery) on portal hypertension and its associated upper digestive tract bleeding. METHODS: A retrospective study was made on clinical da- ta of 140 patients undergoing triplex operation, who had suffered from portal hypertension and upper digestive tract bleeding. RESULTS: Postoperative portal pressure was 25-43 cmH2 O ( preoperative portal pressure 27-45 cmH2 O ) with the average reduction of 10 cmH2O. One patient (0.7%) died of cerebrovascular disease. Five patients (3.5%) suffered from mild hepatic encephalopathy, which was ameliorated through conservative treatment. Lymphatic fistula occurred in 3 patients (2.1% ) who recovered without treatment 5, 10 days and 3 months after operation respectively. One hundred patients were followed up for 1 month to 6 years without recurrent hemorrhage or hepatic encephalopathy. Hypersplenism and ascites disappeared in 70 patients (70% ) and 80 patients (80% ) respectively. A significant reduction of ascites was seen in 12 patients(12% ). The arti- ficial vessels remained unblocking detected by B type ultra- sonography and Doppler sonography in 95 patients (95% ). CONCLUSION: Triplex operation is suitable for patients with the following portal hypertensions; portal hyperten- sion caused by simple occlusion of the hepatic vein (a patho- logical type of Budd-Chiari syndrome); thrombosis of the portal vein or prehepatic portal hypertension because of cavernous transformation; intrahepatic portal hypertension with rebleeding after splenectomy or non-operation, and those patients with liver function in grade A or B according to the Child-Pugh classification. | Liu-Shun Feng, Ke Li, Qi-Ping Peng, Xiu-Xian Ma, Yong-Fu Zhao, Pei-Qin Xu and Xiao-Ping Chen Zhengzhou, China Department of General Surgery, First Affiliated Hospi- tal , Zhengzhou University, Zhengzhou 450052 , China Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China | 2004 | Hepatobiliary & Pancreatic Diseases International2004，3，4： | 9 |
| 2 | Detection of Repair of the Zone of Calcified Cartilage with Osteoarthritis through Mesenchymal Stem Cells by Ultrashort Echo Time Magnetic Resonance Imaging显示文摘 | Quan Zhou Shao-Lin Li Ya-Jun Ma Vicki de Tal Wei Li Ying-Hua Zhao | 2018 | Chinese Medical Journal2018，，9： | 5 |
| 3 | Management of severe Budd-Chiari syndrome:report of 147 cases显示文摘BACKGROUND:Budd-Chiari syndrome (BCS) is an un- common disorder caused by the obstruction of hepatic ve- nous outflow and/or the inferior vena cava. Major thera- peutic approaches include operation and radiological inter- vention. This study was conducted to investigate the treat- ment of severe BCS. METHODS: The clinical data of 147 patients with severe BCS who had been treated at our hospital from November 1994 to December 2003 were retrospectively analyzed. RESULTS: One hundred twenty-one patients with BCS un- derwent surgery, including mesocaval C type shunt with ar- tificial graft (82 patients), splenojugular shunt (37), meso- jugular shunt (2), percutaneous transhepatic recanalization and dilatation and/or stent placement of the main hepatic vein (MHV) (12), and combined percutaneous transhepa- tic angioplasty (PTA) and stent placement of the inferior vena cava and mesocaval shunt (14). Follow-up for 6-108 months showed excellent results in 102 patients (69.4%), good results in 40 (27.2% ), and 5 deaths. CONCLUSION: Good results could be obtained in most of patients with BCS after different surgical treatments accord- ing to the pathological changes of the IVC and MHV. | Liu-Shun Feng, Qi-Ping Peng , Ke Li, Xiu-Xian Ma, Yong-Fu Zhao, Xue-Xiang Ye, Pei-Qin Xu and Xiao-Ping Chen Zhengzhou, China Department of General Surgery, First Affiliated Hospi- tal , Zhengzhou University, Zhengzhou 450052 , China and Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China | 2004 | Hepatobiliary & Pancreatic Diseases International2004，3，4： | 2 |
| 4 | Scar prevention and remodeling: a review of the medical, surgical, topical and light treatment approaches显示文摘 | Kerwin LY E1 Tal AK Stiff MA | 2014 | Int J Dermatol2014，53，8： | 1 |
| 5 | A short form for clinical assessment of quality of life among hypertensive patients显示文摘 | Testa MA e tal | 1989 | Am J Prev Med1989，5，2： | 1 |
| 6 | Preparative separation and purification of rosavin in Rhodiola rosea by macroporous adsorption resins显示文摘 | Ma CY Tal GJ Tang J | 2009 | Separation and Purification Technology2009，69，： | 1 |
| 7 | Nocardia abscess during treatment of brain toxoplasmosis in a patient with aids,utility of proton MR spectroscopy and diffusion-weighted imaging in diagnosis显示文摘 | Jose LS Tal MA Fernando GR | 2006 | Clinical Neurology and Neurosurgery2006，108，5： | 1 |
| 8 | Fructose-Induced fatty liver disease hepatic effects of blood pressure and plasma triglyceride reduction显示文摘 | Mor Oron-Herman Maria Crozuvski Tal ma Ro sent hal et at | 2005 | Hyperte-nsion2005，45，5： | 1 |
| 9 | Scar prevention and remodeling: a review of the medical, surgical, topical and light treatment approaches 显示文摘 | Kerwin LY El Tal AK Stiff MA | 2014 | Int J Dermatol2014，53，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员